Episode 7: In this episode of JTO Insights, Editor-in-Chief Dr. Alex Adjei and Associate Editor Dr. Tom John host Dr. Masahiro Torasawa, the corresponding author of "Tumor Inflammation–Associated Neurotoxicity Masquerading as Severe Immune Effector Cell–Associated Neurotoxicity Syndrome in a Patient With SCLC Treated With Tarlatamab: A Case Report" published in the Journal of Thoracic Oncology July issue.
Also featured in this episode is the article "TTF-1 Expression in Lung Adenocarcinoma: Clinicopathologic, Genomic, and Immunophenotypic Correlates and Outcomes to Immunotherapy-Based Treatments and KRASG12C Inhibitors" by Di Federico et al.Articles discussed:
Tumor Inflammation–Associated Neurotoxicity Masquerading as Severe Immune Effector Cell–Associated Neurotoxicity Syndrome in a Patient With SCLC Treated With Tarlatamab: A Case Report
TTF-1 Expression in Lung Adenocarcinoma: Clinicopathologic, Genomic, and Immunophenotypic Correlates and Outcomes to Immunotherapy-Based Treatments and KRASG12C Inhibitors
July 2026 Issue